Evidence map›Paper›PMID 26649134›Full record

ArticleOxidative medicine and cellular longevity2016

Longxuetongluo Capsule Improves Erythrocyte Function against Lipid Peroxidation and Abnormal Hemorheological Parameters in High Fat Diet-Induced ApoE-/- Mice.

Jiao Zheng, Binglin Liu, Qixing Lun, Weijuan Yao, Yunfang Zhao, Wei Xiao, Wenzhe Huang, Yonghua Wang, Jun Li, Pengfei Tu

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Potential therapeutic mechanisms ofFrontiers in pharmacology · 2025
    Review
  3. Article
  4. Journal of advanced research · 2021
    Article
  5. Article
  6. Article
  7. Antioxidant Effects ofOxidative medicine and cellular longevity · 2019
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Jiao ZhengModern Research Center for Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China.
Binglin LiuModern Research Center for Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China ; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100102, China.
Qixing LunModern Research Center for Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China ; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100102, China.
Weijuan YaoHemorheology Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.
Yunfang ZhaoModern Research Center for Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China.
Wei XiaoNational Key Laboratory of Pharmaceutical New Technology for Chinese Medicine, Jiangsu Kanion Pharmaceutical Co. Ltd., Lianyungang 222001, China.
Wenzhe HuangNational Key Laboratory of Pharmaceutical New Technology for Chinese Medicine, Jiangsu Kanion Pharmaceutical Co. Ltd., Lianyungang 222001, China.
Yonghua WangNational Key Laboratory of Pharmaceutical New Technology for Chinese Medicine, Jiangsu Kanion Pharmaceutical Co. Ltd., Lianyungang 222001, China.
Jun LiModern Research Center for Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China.
Pengfei TuModern Research Center for Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China.
Beijing University of Chinese Medicine · CNNew Technology (Israel) · ILPeking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chinese dragon's blood, the red resin of Dracaena cochinchinensis, one of the renowned traditional medicines, has been used to facilitate blood circulation and disperse blood stasis for thousands of years. Phenolic compounds are considered to be responsible for its main biological activities. In this study, total phenolic compounds of Chinese dragon's blood were made into capsule (Longxuetongluo Capsule, LTC) and their effects on the abnormal hemorheological properties were examined by high fat diet (HFD) induced ApoE-/- mice. Compared to the model group, LTC recovered the abnormal hemorheological parameters in HFD-induced ApoE-/- mice by reducing whole blood viscosity (WBV) at high rate and improving erythrocyte function. In conclusion, LTC could ameliorate erythrocyte deformability and osmotic fragility through the reduction of lipid peroxidation on plasma and erythrocyte membranes in HFD-induced ApoE-/- mice, which supported the traditional uses of Chinese dragon's blood as an effective agent for improving blood microcirculation in hypercholesterolemia.

Indexed as

HypercholesterolemiaAnimalsApolipoproteins ECapsulesDietary FatsErythrocyte DeformabilityErythrocytesMedicine, Chinese TraditionalMicePlant PreparationsApolipoproteins ECapsulesDietary FatsPlant Preparations

Identifiers

PMID26649134
PMCPMC4663336
OpenAlexW2215955563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.